- Home
- IMRN vs PMD Comparison
IMRN vs PMD Comparison
Compare IMRN & PMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- PMD
- Stock Information
- Founded
- IMRN 1994
- PMD 1986
- Country
- IMRN Australia
- PMD United States
- Employees
- IMRN N/A
- PMD N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- PMD Medical Specialities
- Sector
- IMRN Health Care
- PMD Health Care
- Exchange
- IMRN Nasdaq
- PMD Nasdaq
- Market Cap
- IMRN 15.0M
- PMD 13.7M
- IPO Year
- IMRN N/A
- PMD N/A
- Fundamental
- Price
- IMRN $2.11
- PMD $2.67
- Analyst Decision
- IMRN Strong Buy
- PMD
- Analyst Count
- IMRN 1
- PMD 0
- Target Price
- IMRN $5.00
- PMD N/A
- AVG Volume (30 Days)
- IMRN 6.2K
- PMD 58.8K
- Earning Date
- IMRN 12-31-2024
- PMD 11-12-2024
- Dividend Yield
- IMRN N/A
- PMD N/A
- EPS Growth
- IMRN N/A
- PMD N/A
- EPS
- IMRN N/A
- PMD N/A
- Revenue
- IMRN $3,271,194.00
- PMD $20,258,000.00
- Revenue This Year
- IMRN N/A
- PMD N/A
- Revenue Next Year
- IMRN N/A
- PMD N/A
- P/E Ratio
- IMRN N/A
- PMD N/A
- Revenue Growth
- IMRN 171.67
- PMD N/A
- 52 Week Low
- IMRN $1.59
- PMD $1.64
- 52 Week High
- IMRN $5.96
- PMD $3.95
- Technical
- Relative Strength Index (RSI)
- IMRN 52.87
- PMD 39.39
- Support Level
- IMRN $2.05
- PMD $1.11
- Resistance Level
- IMRN $2.23
- PMD $2.91
- Average True Range (ATR)
- IMRN 0.16
- PMD 0.37
- MACD
- IMRN 0.02
- PMD -0.08
- Stochastic Oscillator
- IMRN 47.06
- PMD 36.10
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About PMD Psychemedics Corporation
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.